BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Noorden CJF, Hira VVV, van Dijck AJ, Novak M, Breznik B, Molenaar RJ. Energy Metabolism in IDH1 Wild-Type and IDH1-Mutated Glioblastoma Stem Cells: A Novel Target for Therapy? Cells 2021;10:705. [PMID: 33810170 DOI: 10.3390/cells10030705] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Majc B, Novak M, Lah TT, Križaj I. Bioactive peptides from venoms against glioma progression. Front Oncol 2022;12:965882. [DOI: 10.3389/fonc.2022.965882] [Reference Citation Analysis]
2 Zhang Y, Liu Y, Lang F, Yang C. IDH mutation and cancer stem cell. Essays Biochem 2022:EBC20220008. [PMID: 35611837 DOI: 10.1042/EBC20220008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sisakht AK, Malekan M, Ghobadinezhad F, Firouzabadi SNM, Jafari A, Mirazimi SMA, Abadi B, Shafabakhsh R, Mirzaei H. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment. Cell Mol Neurobiol 2022. [PMID: 35411434 DOI: 10.1007/s10571-022-01212-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Furst L, Atkins RJ, Dinevska M, Stylli SS, Corcoran NM, Hovens CM, Mantamadiotis T. Identification and isolation of slow-cycling glioma stem cells. Methods in Cell Biology 2022. [DOI: 10.1016/bs.mcb.2022.02.004] [Reference Citation Analysis]
5 Alzial G, Renoult O, Paris F, Gratas C, Clavreul A, Pecqueur C. Wild-type isocitrate dehydrogenase under the spotlight in glioblastoma. Oncogene 2021. [PMID: 34764443 DOI: 10.1038/s41388-021-02056-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
6 van Noorden CJF, Breznik B, Novak M, van Dijck AJ, Tanan S, Vittori M, Bogataj U, Bakker N, Khoury JD, Molenaar RJ, Hira VVV. Cell Biology Meets Cell Metabolism: Energy Production Is Similar in Stem Cells and in Cancer Stem Cells in Brain and Bone Marrow. J Histochem Cytochem 2021;:221554211054585. [PMID: 34714696 DOI: 10.1369/00221554211054585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Dadras MS, Caja L, Mezheyeuski A, Liu S, Gélabert C, Gomez-Puerto MC, Gallini R, Rubin CJ, Ten Dijke P, Heldin CH, Moustakas A. The polarity protein Par3 coordinates positively self-renewal and negatively invasiveness in glioblastoma. Cell Death Dis 2021;12:932. [PMID: 34642295 DOI: 10.1038/s41419-021-04220-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Shapovalov V, Kopanitsa L, Pruteanu LL, Ladds G, Bailey DS. Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells. Cancers (Basel) 2021;13:3780. [PMID: 34359681 DOI: 10.3390/cancers13153780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Castresana JS, Meléndez B. Molecular and Cellular Mechanisms of Glioblastoma. Cells 2021;10:1456. [PMID: 34200693 DOI: 10.3390/cells10061456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lah Turnšek T, Jiao X, Novak M, Jammula S, Cicero G, Ashton AW, Joyce D, Pestell RG. An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5. Int J Mol Sci 2021;22:4464. [PMID: 33923334 DOI: 10.3390/ijms22094464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]